J.P. Morgan 2020 – 38th Annual Healthcare Conference
January 13-16, 2020
San Francisco, USA
“ENYO Pharma team was present at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.”
Read next in 'Events'
- Alport Connect 2024, the annual Alport syndrome patient and family meeting in US
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week